Strategic expansion Aenova Group is actively expanding its Killorglin facility in Ireland to support amorphous solid dispersions and inhalation powders, signaling opportunities to supply specialized formulation and development services, equipment, and contract manufacturing for advanced drug delivery.

Leadership evolution Recent leadership appointments, including a new Managing Director for the Latina sterile technologies center and a COO, indicate strategic emphasis on operational excellence and global growth, suggesting openings for partnerships in process optimization, supply chain enhancements, and CDMO collaborations.

Innovation position Recognition as a top innovative product provider and ongoing investments in state-of-the-art spray drying platforms position Aenova as a preferred partner for customers seeking innovative formulation capabilities, advanced manufacturing platforms, and scale-up expertise.

Sustainability edge Sustainability accolades at industry events and a clear emphasis on quality and responsible production create a sales angle for eco-conscious clients, particularly in regulated markets seeking high standards and credible green credentials.

Full‑spectrum capabilities With a broad portfolio spanning development and production across dosage forms and dietary supplements, Aenova offers end-to-end CDMO services, enabling cross-sell opportunities to clients needing integrated development, manufacturing, packaging, and global distribution support.